# Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

> **NCT01574703** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 4595 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** placebo
- **DRUG:** varenicline tartrate
- **DRUG:** bupropion hydrochloride
- **DRUG:** Nicotine Replacement Therapy Patch

## Key facts

- **NCT ID:** NCT01574703
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 4595 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01574703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01574703, "Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01574703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*